文献速递甲状腺疾病

甲状腺癌免疫图谱揭示两种主要表型:ATC样与PDTC样

Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like.
PubMed 文献 · J Clin Endocrinol Metab · 2019-01-01

该回顾性研究对25例PTC、14例PDTC、13例ATC及7例正常甲状腺组织进行基因表达谱分析,发现免疫相关基因集在ATC中上调最显著,其次为PTC,PDTC最弱;ATC和部分PTC呈现巨噬细胞和CD8+效应T细胞浸润并伴免疫检查点分子上调,而多数PDTC和部分PTC免疫浸润贫乏,提示甲状腺癌存在ATC样和PDTC样两种免疫表型。

要点

  • 甲状腺癌免疫相关基因表达上调程度为ATC>PTC>>PDTC。
  • 多数ATC和约半数PTC呈免疫细胞浸润并伴免疫检查点分子上调。
  • 多数PDTC及部分PTC免疫浸润贫乏,类似正常甲状腺组织。

核心结论

  • 甲状腺癌存在两种主要免疫表型:ATC样(热肿瘤和改变型免疫抑制肿瘤)与PDTC样(改变型排斥肿瘤和冷肿瘤)。

研究设计与样本

  • 回顾性研究,纳入25例甲状腺乳头状癌、14例低分化甲状腺癌、13例未分化甲状腺癌和7例正常甲状腺组织样本。
  • 采用Nanostring平台nCounter PanCancer Immune Profiling Panel对RNA样本进行基因表达谱分析。

主要发现

  • 与正常甲状腺相比,ATC、PTC和PDTC中均检测到大量调控基因,免疫相关基因集显著上调(ATC > PTC > > PDTC)。
  • 多数ATC和约半数PTC显示巨噬细胞和CD8+效应表型T细胞浸润的微环境,部分T细胞功能耗竭。
  • 多数PDTC、正常甲状腺样本及剩余部分PTC显示免疫细胞浸润贫乏或缺失。
  • ATC和PTC中可检测到抑制性免疫检查点介质上调,包括PDL1、PDL2、PD1、LAG-3、TIM-3、PVR和TIGIT。

临床怎么用

  • 甲状腺癌免疫表型分型可能为免疫治疗靶点选择和疗效生物标志物开发提供依据。
  • ATC样免疫表型(热肿瘤/免疫抑制)与PDTC样免疫表型(冷肿瘤/排斥)的区分有助于分层管理。

局限性

  • 回顾性研究,样本量有限。
  • Findings需在局部晚期或转移性癌组织中确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The understanding of the mechanisms underlying thyroid cancer immune escape can lead to the identification of new molecular targets and/or efficacy biomarkers. For this purpose, we performed immune expression profiling in thyroid cancers to obtain a comprehensive view on immune mechanisms activated during cancer progression. METHODS: The study was conducted retrospectively in 25 papillary thyroid carcinomas (PTCs), 14 poorly differentiated thyroid carcinomas (PDTC), 13 anaplastic thyroid carcinomas (ATCs), and 7 normal thyroid (NT) tissue samples. Gene expression profiling was obtained on RNA samples using the Nanostring platform and its nCounter PanCancer Immune Profiling Panel. RESULTS: Gene expression comparison of ATC, PTC, and PDTC vs NT showed high number of regulated genes in cancer samples. In detail, immune-related gene sets were significantly upregulated (ATC > PTC > > PDTC). Most ATC and approximately half of PTC showed a microenvironment infiltrated by macrophages and T-cells with CD8+ effector phenotype, part of which appeared to be functionally exhausted. Conversely, most PDTC, as NT samples, as the remaining part of PTC, displayed a poor or absent infiltration by immune cells. Interestingly, an upregulation of inhibitory immune checkpoint mediators, including PDL1, PDL2, PD1, LAG-3, TIM-3, PVR, and TIGIT, could be detected in ATC and PTC. CONCLUSIONS: These data indicated the existence of two major immune phenotypes in thyroid carcinoma: an ATC-like one, including hot and altered-immunosuppressed tumors and a PDTC-like one, including altered-excluded and cold tumors. Confirmation of the findings in locally advanced or metastatic cancer tissues is expected to have important immunotherapeutic implications.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Giannini R, Moretti S, Ugolini C, et al. Immune Profiling of Thyroid Carcinomas Suggests the Existence of Two Major Phenotypes: An ATC-Like and a PDTC-Like. J Clin Endocrinol Metab. 2019. PMID: 30882858. doi:10.1210/jc.2018-01167

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。